About Cayman Chemical Forensics
Founded more than 40 years ago, Cayman Chemical Forensics specialises in the synthesis, purification and characterisation of biochemicals for forensic and toxicological applications. The company develops analytical reference standards that support the identification, characterisation and investigation of emerging drugs and controlled substances. Its scientific expertise spans synthetic cannabinoids, cathinones, phenethylamines, amphetamines, indanes, opioids, benzodiazepines, tryptamines and phytocannabinoids. These materials enable forensic laboratories, toxicology laboratories and academic researchers to perform qualitative and quantitative analyses, investigate novel psychoactive substances and study physiological and toxicological effects.
The forensic portfolio includes high-purity analytical standards, synthesised reference materials and certified reference materials for laboratory testing workflows. Cayman Chemical also provides supporting resources for drug identification, spectral analysis and forensic method development. Its certified reference materials are produced to support traceability requirements and are accredited to ISO/IEC 17025:2017 and ISO 17034:2016 standards. The company’s products are used in chromatography, mass spectrometry and other analytical techniques employed in forensic and toxicology laboratories.
Europa Biosite’s subsidiaries distribute for Cayman Chemical Forensics in Austria, Belgium, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden, Switzerland and the United Kingdom.